For the Inventor, By the Inventor

Enter assignee name

Sundbyberg, Sweden

Biolamina Ab

USPTO Granted Patents = 22

CIPO Patents = 1

EPO Patents = 10

Trademarks = 6

Forward Citations = 21

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Karl Kristian Tryggvason (14 out of 30 patents)

Sergey Rodin (6 out of 7 patents)

Anna Domogatskaya (5 out of 6 patents)

4. Kristian Tryggvason (5 out of 5 patents)

5. Outi Hovatta (4 out of 4 patents)

6. Karl Tryggvason (4 out of 5 patents)

7. Yan Wen Yap (3 out of 3 patents)

8. Agnete Kirkeby (2 out of 2 patents)

9. Malin Pernilla Parmar (2 out of 2 patents)

10. Sun Yi (2 out of 2 patents)

11. Louise Kristina Hagbard (2 out of 2 patents)

12. Carl Gunnar Jesper Ericsson (2 out of 2 patents)

13. Katherine Rachel Cameron (2 out of 2 patents)

14. David Colin Hay (2 out of 3 patents)

15. Stuart John Forbes (2 out of 2 patents)

22 patents: Sort by Forward Citations

1. 12680078 - Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221 (2026-07-14),

2. 12516287 - Methods for producing retinal pigment epithelium cells (2026-01-06),

3. 12391915 - Maintenance of differentiated cells with laminins (2025-08-19),

4. 12378527 - Differentiation of pluripotent stem cells using laminins LN-511, LN-521 and LN-221 (2025-08-05),

5. 12195757 - Methods of producing RPE cells (2025-01-14),

6. 11767509 - Methods of producing RPE cells (2023-09-26),

7. 11713448 - Methods for producing hepatocytes (2023-08-01),

8. 11236302 - Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases (2022-02-01),

9. 11155781 - Maintenance of differentiated cells with laminins (2021-10-26),

10. 11001807 - Differentiation of pluripotent stem cells and cardiac progenitor cells into striated cardiomyocyte fibers using laminins LN-511, LN-521 and LN-221 (2021-05-11),

11. 10889801 - Methods of producing RPE cells (2021-01-12),

12. 10829733 - Composition and method for enabling proliferation of pluripotent human stem cells (2020-11-10),

13. 10683486 - Methods for producing hepatocytes (2020-06-16),

14. 10344259 - Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases (2019-07-09),

15. 10240124 - Cell culture substrate comprising a laminin and a cadherin (2019-03-26),

Biolamina AB is a leading biotech company dedicated to developing and producing advanced cell culture solutions. With a focus on human stem cells, Biolamina offers high-quality laminin-based products that enhance cell growth, proliferation, and differentiation. The company's innovative technologies are utilized by researchers and pharmaceutical companies worldwide to accelerate discoveries and advancements in regenerative medicine and drug discovery.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

22 Patents

#2 in Sundbyberg

#298 in Sweden

#28,690 in the World

Sundbyberg, Sweden

Biolamina Ab

Forward Citations = 21

21 inventors:

Karl Kristian Tryggvason (14 out of 30 patents)

Sergey Rodin (6 out of 7 patents)

Anna Domogatskaya (5 out of 6 patents)

4. Kristian Tryggvason (5 out of 5 patents)

5. Outi Hovatta (4 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…